Screening of Big Pharma’s Library against Various in-house Biological Targets

Open innovation initiatives provide opportunities for collaboration and sharing of knowledge and experience between industry, academia, and government institutions. Through open innovation, Merck is offering a Mini Library of 80 carefully selected compounds from previous research and development pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Knez, Damijan, Gobec, Stanislav, Hrast, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320114/
https://www.ncbi.nlm.nih.gov/pubmed/35889355
http://dx.doi.org/10.3390/molecules27144484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320114/
https://www.ncbi.nlm.nih.gov/pubmed/35889355
http://dx.doi.org/10.3390/molecules27144484

Ejemplares similares